VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds

Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
You are here: IndiaNotes

Filter search : Quote Research All

Companies for search string : Lupin

Lupin Ltd. Lupin [BSE: 500257 || NSE: LUPINEQ]

Reports for search string : Lupin

Buy Lupin; Sell DCB Bank, Britannia
Post the breakdown from the rising trend line drawn on hourly chart, index likely to retest its recent swing low of 24048 and any break below this level will lead to an extens...
Way2wealth, 20 Mar 2018
Investment Idea: Buy Century Ply, Godrej Ind, Lupin
Going forward, Nifty has an immediate hurdle near 10618 and any sustain move beyond this level will drive index higher towards 10655 / 10690 levels respectively. On the flip side, 10545 will act as an...
Way2wealth, 27 Feb 2018
Buy Cadila Healthcare, Lupin, CAPF, ITC
We assign BUY recommendation on the stock with a Target Price of Rs540 per share, based on 22x FY20E EPS of Rs24.6/share.
Reliance Securities, 12 Feb 2018
Lupin Q3FY18: Outlook Remains Weak; Maintain Hold
Lupin (LPC) continued to deliver a weak performance in 3QFY18 from all operational metrics. Its revenue, EBITDA and PAT declined by 11.3% YoY, 43.5% YoY and 65% YoY to Rs39.7bn, Rs6.9bn, Rs2.2bn, resp...
Reliance Securities, 09 Feb 2018
Derivatives: Sell HCL tech, Buy Dish TV
After last 3 days of sharp correction, today markets will open on positive note on back of strong global indices but on higher side nifty will continue to see stiff resistance around 10640-10680 level...
Way2wealth, 07 Feb 2018
Derivatives: Markets can swing on either side on back of Union Budget announcements
On back of strong lobal cues, today domestic markets are expected to open on flat to positive note but thereafter will continue to trade in narrow band in first half of session. In second half of trad...
Way2wealth, 01 Feb 2018
Buy Federal Bank, PowerGrid, IOC; Sell Lupin
We reiterate our BUY recommendation on the stock with an upward revised Target Price of Rs 150 based on 2.3x FY19E Adjusted book value.
Reliance Securities, 10 Jan 2018
Derivatives Idea: Buy South Bank and BPCL
On higher side nifty will see minor resistance around 10660-10680 and from those levels profit booking can be seen. However, overall sentiment remains bullish and any dips towards 10550...
Way2wealth, 09 Jan 2018
Derivatives outlook and recommendations for 08 Jan' 18
Taking clues from strong global markets, domestic indices will open with positive gap. On lower side fresh put writing was seen at 10500-10400 option and that 100 points band will prove as storng supp...
Way2wealth, 08 Jan 2018
Derivatives outlook and recommendations for 27 Dec' 17
After yesterday’s late pullback, today markets are expected to open on flat note but on lower side will find strong support around 10500-10470 levels. However, on higher side call writing at 10500-106...
Way2wealth, 27 Dec 2017
Reliance Securities Market Lens (14 Dec 17)
Kotak Mahindra Bank closed 1.5% higher outperforming benchmark NIFTY index by 2% along with sharp surge in volume. We maintain our BUY recommendation on the stock with an unrevised Target Price of Rs ...
Reliance Securities, 14 Dec 2017
Reliance Securities Market Lens (13 Dec 17)
Valuing at 50x CY18E (15% discount to its mean multiple of 60x (2005-15) earnings of Rs32.1/share, we have BUY recommendation with a Target Price of Rs 1,607.
Reliance Securities, 13 Dec 2017
Pharmaceutical Sector Update: Outlook continue to remain a bit muted
Outlook for Indian pharmaceutical companies continue to remain a bit muted given multiple headwinds in their core markets of US and India and dwindling margins, with higher R&D investments. This also ...
Equirus Securities, 22 Nov 2017
Lupin: Warning letter a negative surprise; assign Short
USFDA today issued a combined warning letter (WL) to LPC’s formulation manufacturing facilities at Goa (oral solids) and Indore (Pithampur Unit II, opthalmics and oral solids). This came as a negative...
Equirus Securities, 14 Nov 2017
Lupin: USFDA Warning Letter Entails Further Downside Risk to US Biz; HOLD
We have reduced our target multiple to 18x (from 19x) and trimming down our earnings estimate by 7%/16% for FY18E/FY19E on the back of WL to its two key plants, we maintain our HOLD recommendation on ...
Reliance Securities, 13 Nov 2017
Lupin: Goa and Indore plant receives Warning Letter
Near term pressure to persist; stock factoring most of the negatives: LPC has invested ~INR60b on R&D between FY16-18E (much higher than what it invested in a decade prior to that). We maintain Buy wi...
Motilal Oswal, 08 Nov 2017
Derivatives outlook and recommendations for 08 Nov 17
Markets are expected to open on flat to positive note in today’s session but on higher side will see stiff resistance around 10400-10440 levels and from those levels profit booking is expected. Overal...
Way2wealth, 08 Nov 2017
SMC's outlook for the day (30 Oct 17)
The markets may see a green start on the back positive Asian cues. Asian stocks were mixed as investors continued to digest earnings, while bond and currency markets awaited...
SMC, 30 Oct 2017
Pharma Sector Q2FY18 results preview: Sequential Improvement Expected; Long-term Prospects Remain Intact
The pharmaceutical companies under our coverage universe are expected to report a muted performance on YoY basis in 2QFY18 due to multiple headwinds in the US led by increasing pricing pressure, lack ...
Reliance Securities, 17 Oct 2017
Dynamic Levels: Support and resistance levels for top-10 Nifty-50 stocks (11 October'17)
Dynamic Levels are sharing with us the Support and Resistance levels for their top-10 Nifty-50 stocks for 11 October'17. They include UPL, Lupin, Power Grid, Axis Bank, IndusInd Bank, Coal India, Bhar...
Dynamic Equities Pvt Ltd, 11 Oct 2017
View All

Intraday Tips

What are technical calls?
* SEBI certified analyst

View Stock Advice by: